Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1999
05/06/1999WO1999021855A1 Pleuromutilin derivatives as antimicrobials
05/06/1999WO1999021582A2 Application of tnf antagonists as medicaments for treating septic diseases
05/06/1999WO1999021580A1 Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof
05/06/1999WO1999021568A1 Metal/thiol biocides
05/06/1999WO1999021562A1 Treatment of female sexual dysfunction
05/06/1999WO1999011651A3 3-descladinose 6-o-substituded erythromycin derivatives
05/06/1999WO1999009154A3 Novel hiv-specific synthetic oligonucleotides and methods of their use
05/06/1999WO1999008691A3 Use of locally delivered metal ions for treatment of periodontal disease
05/06/1999EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB)
05/06/1999EP0913479A2 Adenine glycosylase
05/06/1999EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993
05/06/1999EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
05/06/1999EP0913474A2 Dbpa, a helicase from Staphylococcus aureus
05/06/1999EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor
05/06/1999EP0913157A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method
05/06/1999EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency
05/06/1999EP0913151A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
05/06/1999EP0912743A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912740A1 Rantes homolog from prostate
05/06/1999EP0912731A2 Secreted proteins
05/06/1999EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
05/06/1999EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines
05/06/1999EP0912574A1 Beta-lactams
05/06/1999EP0912561A1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
05/06/1999EP0912560A1 Indole derivatives for the treatment of osteoporosis
05/06/1999EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
05/06/1999EP0912526A1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/06/1999EP0912509A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/06/1999EP0912194A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease
05/06/1999EP0912193A1 Vaccine to prevent streptococcal endocarditis
05/06/1999EP0912170A1 Hiv protease inhibitors useful for the treatment of aids
05/06/1999EP0912097A1 Antimicrobial peroxidase compositions
05/06/1999EP0912095A1 Phosphate composition and its utilization
05/06/1999EP0912085A1 Precise efficacy assay methods for active agents including chemotherapeutic agents
05/06/1999EP0746333B1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv)
05/06/1999EP0721457B1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity
05/06/1999EP0684818B1 Method of reversing resistance of hiv-1 strains to zidovudine
05/06/1999EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase
05/06/1999EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv
05/06/1999EP0582581B1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES
05/06/1999EP0576439B1 Monoclonal antibody against lps core
05/06/1999EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
05/06/1999EP0541692B1 Herpes simplex virus vp16 vaccines
05/06/1999CA2658884A1 Metal/thiol biocides
05/06/1999CA2307828A1 6,11-bridged erythromycin derivatives
05/06/1999CA2306790A1 Application of tnf antagonists as medicaments for treating septic diseases
05/05/1999CN1216064A Synthetic HIV genes
05/05/1999CN1216047A Antifungic and antibaterial peptide
05/05/1999CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors
05/05/1999CN1215996A Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
05/05/1999CN1215994A Rnase L activators and antisense oligonucleotides effective to treat RSV infections
05/05/1999CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate
05/05/1999CN1215610A Antipyretic and antitoxic particles and preparing method thereof
05/05/1999CN1215597A 'Fuchang'an' for treating abdominal troubles and its preparing method
05/05/1999CN1043231C Monohydrate of (E)-alpha-deoxy-alpha-(fluoro-methylene) cytidine
05/04/1999US5900488 Method for treating mycosis using imidazolylacetonitrile derivatives
05/04/1999US5900486 Fungicides
05/04/1999US5900430 Cytokine inhibitors
05/04/1999US5900420 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
05/04/1999US5900413 Administering with amoxicillin
05/04/1999US5900401 Remedy for respiratory-tract viral disease
05/04/1999US5900400 Protein
05/04/1999US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles
05/04/1999US5900235 Polypeptides
05/04/1999US5900231 Cosmetic and/or dermatological skin treatment
05/04/1999CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
04/1999
04/30/1999CA2249056A1 Lacc
04/30/1999CA2248996A1 Novel ornithine carbamoyltransferase
04/29/1999WO1999020794A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors
04/29/1999WO1999020759A1 Chemokines with amino-terminal modifications
04/29/1999WO1999020653A1 Low-toxicity human interferon-alpha analog
04/29/1999WO1999020650A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
04/29/1999WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers
04/29/1999WO1999020641A1 New triplex forming oligonucleotides and their use in anti-hbv
04/29/1999WO1999020639A2 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
04/29/1999WO1999020631A1 Process for producing 3-cephem compounds
04/29/1999WO1999020628A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
04/29/1999WO1999020627A1 Carbapenem antibacterial compounds, compositions and methods of treatment
04/29/1999WO1999020624A1 Bicyclic kinase inhibitors
04/29/1999WO1999020599A1 Pharmaceutically active compounds and methods of use
04/29/1999WO1999020310A1 J-chain and analogues as epithelial cell targeting conjugates
04/29/1999WO1999020307A1 NOVEL pheS (BETA)
04/29/1999WO1999020306A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
04/29/1999WO1999020305A1 Veterinary vaccines
04/29/1999WO1999020304A1 Passive immunization against clostridium difficile disease
04/29/1999WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/29/1999WO1999020270A1 Carbapenem antibacterial compounds, compositions and methods of treatment
04/29/1999WO1999020269A1 Antibacterial carbapenems, compositions and methods of treatmemt
04/29/1999WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis
04/29/1999WO1999020250A1 Topical antifungal composition
04/29/1999WO1999020107A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
04/29/1999WO1999020098A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
04/29/1999WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate
04/29/1999WO1999005165A8 Streptogramines, their preparation and compositions containing them
04/29/1999WO1999003452A9 Methods of removing residual solvent from nasal drug delivery compositions
04/29/1999WO1999001473A3 Anti-bacterial methods and materials
1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 1798